The Peritoneum pp 171-208 | Cite as

Peritoneal Macrophages

  • Gere S. diZerega
  • Kathleen E. Rodgers


Cells composing the mononuclear phagocyte system share a similar morphology, bone marrow origin, and avid phagocytic capacity. Cells currently assigned to the mononuclear phagocyte system are listed in Table 6.1 and include precursor cells in the bone marrow, and monocytes and macrophages present in the tissues and body cavities under normal conditions, inflammation, and postsurgical repair.


Peritoneal Cavity Peritoneal Macrophage Mononuclear Phagocyte Macrophage Function Reactive Oxygen Intermediate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe H, Rodgers KE, Ellefson D, diZerega GS. (1989). Kinetics of interleukin-1 secretion by murine macrophages recovered from the peritoneal cavity after surgery. J Surg Res. 47: 178–182.PubMedCrossRefGoogle Scholar
  2. Abe H, Rodgers KE, Campeau D, Girgis W, Ellefson DD, diZerega GS. (1990). The effect of intraperitoneal administration of sodium tolmetin-hyaluronic acid on the postsurgical cell infiltration in vivo. J Surg Res. 49: 322–327.PubMedCrossRefGoogle Scholar
  3. Abe H, Rodgers KE, Ellefson D, diZerega GS. (1991). Kinetics of interleukin-1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity after surgery. J Invest Surg. 4: 141–151.PubMedCrossRefGoogle Scholar
  4. Adams DO, Johnson WJ, Marino PJ. (1982). Mechanisms of target recognition and destruction in macrophage mediated tumor cytotoxicity. Fed Proc 41:134.Google Scholar
  5. Adams DO. (1983). The biology of the granuloma. In: Ioachim H, ed. Pathology of Granulomas. New York: Raven Press; 1–20.Google Scholar
  6. Adams DO, Nathan CF. (1983). Molecular mechanisms in tumor-cell killing by activated macrophages. Immunol Today. 4: 166–170.CrossRefGoogle Scholar
  7. Adams DO, Hall T, Steplewski Z, Koprowski H. (1984). Tumor undergoing rejection induced by monoclonal antibodies of the IgG2α isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci USA. 81: 3506–3510.PubMedCrossRefGoogle Scholar
  8. Adams DO, Marino P. (1984a). Activation of mononuclear phagocytes for destruction of tumor cells as a model for the study of macrophage development. In: Gordon AS, Silver R, LoBue J, eds. Contemporary Topics in Hematology-Oncology. New York: Plenum Press; 69–136.Google Scholar
  9. Adams DO, Hamilton TA. (1987). Molecular basis of signal transduction in macrophage activation induced by IFN–γ and by second signals. Immunol Rev. 97: 1–27.CrossRefGoogle Scholar
  10. Adams DO, Hamilton TA. (1988). Phagocytic cells: cytotoxic activities of macrophages. In: Gallin JI, Goldstein IM, Synderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press; 471–492.Google Scholar
  11. Alexander P, Evans R. (1971). Endotoxin and double stranded RNA render macrophages cytotoxic. Nature. 232: 76–79.Google Scholar
  12. Allison AC. (1978). Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol Rev. 40: 3–27.PubMedCrossRefGoogle Scholar
  13. Axline S. (1970). Functional biochemistry of the macrophages. Semin Hematol. 7: 142–150.PubMedGoogle Scholar
  14. Bevilacqua MP, Schleef RR, Gimbrone MA, Loskutoff DJ. (1986). Regulation of fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest. 73: 587–591.CrossRefGoogle Scholar
  15. Bitterman PB, Wewers MD, Rennard SI, Adelberg S, Crystal RG. (1986). Modulation of alveolar macrophages-derived fibroblast proliferation by alternative macrophage mediators. J Clin Invest. 77: 700–713.PubMedCrossRefGoogle Scholar
  16. Boros DL. (1986). Immunoregulation of granulomatous formation in murine schistosomiasis mansoni. Ann NY Acad Sci. 465: 313–323.PubMedCrossRefGoogle Scholar
  17. Bronson RE, Bentiolami CN, Siebert EP. (1987). Modulation of fibroblast growth and glycosaminoglycan synthesis by interleukin-1. Collagen Rel Res. 7: 323–332.Google Scholar
  18. Bryant SM, Lynch RE, Hill HR. (1982). Kinetic analysis of superoxide anion production by activated and resident murine peritoneal macrophages. Cell Immunol. 96: 46–58.CrossRefGoogle Scholar
  19. Bryant SM, Fukasawa M, Orita H, Rodgers KE, diZerega GS. (1988). Mediation of post-surgical wound healing by macrophages. Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications. New York: Alan R. Liss; 263–290.Google Scholar
  20. Buyalos RP, Rutanem E-M, Tsui E, Halme J. (1991). Release of tumor necrosis factor alpha by human peritoneal macrophages in response to toxic shock syndrome toxin-1. Obstet Gynecol. 78: 182–186.PubMedGoogle Scholar
  21. Calderon J, Williams RT, Unanue ER. (1974). An inhibitor of cell proliferation released by cultures of macrophages. Proc Natl Acad Sci USA. 71: 4273–4277.PubMedCrossRefGoogle Scholar
  22. Chapman HA, Stone OL, Vavrin Z. (1984). Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. J Clin Invest. 73: 806–815.PubMedCrossRefGoogle Scholar
  23. Clark RA, Klebanoff SJ. (1975). Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. J Exp Med. 141: 1442–1457.PubMedCrossRefGoogle Scholar
  24. Diegelmann RF, Cohen IK, Kaplan AM. (1981). The role of macrophages in wound repair: a review. Plast Reconstr Surg. 68: 107–113.PubMedCrossRefGoogle Scholar
  25. Dolynchuk KN, Bowness JM. (1981). The early metabolism of noncollagenous glycoproteins during wound healing. J Surg Res. 31: 218–224.PubMedCrossRefGoogle Scholar
  26. Dower SK, Kronheim SR, March CJ, Conlon PJ, Hopp TP, Gillis S, Urdal DL. (1985). Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med. 162: 501–517.PubMedCrossRefGoogle Scholar
  27. Ebert RH, Florey HW. (1939). The extravascular development of the monocyte observed in vivo. Br J Exp Pathol. 20: 342–351.Google Scholar
  28. Edelson PJ. (1982). Intracellular parasites and phagocytic cells: Cell biology and pathophysiology. Rev Infect Dis. 4: 124–156.PubMedCrossRefGoogle Scholar
  29. Elias JA, Rossman MD, Zurier RB, Daniele RP. (1985). Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am Rev Respir Dis. 131: 94–99.PubMedGoogle Scholar
  30. Esparza I, Green R, Schreiber RD. (1983). Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes. J Immunol. 131:2117–2123.PubMedGoogle Scholar
  31. Estes JE, Pledger WJ, Gillespie GY. (1984). Macrophage derived growth factor for fibroblasts and interleukin-1 are distinct entities. J Leukoc Biol. 35:115– 128.PubMedGoogle Scholar
  32. Fakih H, Baggett B, Holtz G, Tsang KY, Lee JC, Williamson HO. (1987). Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril. 47: 213–217.PubMedGoogle Scholar
  33. Feldman SR, Gonias SL, Pizzo SV. (1985). A model of α2–macroglobulin structure and functions. Proc Natl Acad Sci USA. 82: 5700–5704.PubMedCrossRefGoogle Scholar
  34. Fukasawa M, Bryant SM, Nakamura RM, diZerega GS. (1987). Modulation of fibroblast proliferation by postsurgical macrophages. J Surg Res. 43: 513–520.PubMedCrossRefGoogle Scholar
  35. Fukasawa M, Bryant SM, diZerega GS. (1988a). Incorporation of thymidine by fibroblasts: evidence for complex regulation by postsurgical macrophages. J Surg Res. 45: 460–466.PubMedCrossRefGoogle Scholar
  36. Fukasawa M, Bryant SM, diZerega GS. (1988b). Superoxide anion production by postsurgical macrophages. J Surg Res. 45: 382–388.PubMedCrossRefGoogle Scholar
  37. Fukasawa M, Campeau JD, Yanagihara DL, Rodgers KE, diZerega GS. (1989a). Mitogenic and protein synthetic activity of tissue repair cells: control by the postsurgical macrophage. J Invest Surg. 2: 169–180.PubMedCrossRefGoogle Scholar
  38. Fukasawa M, Yanagihara DL, Rodgers KE, diZerega GS. (1989b). The mitogenic activity of peritoneal tissue repair cells: control by growth factors. J Surg Res. 47: 45–51.PubMedCrossRefGoogle Scholar
  39. Fukasawa M, Campeau D, Girgis W, Bryant SM, Rodgers KE, diZerega GS. (1989c). Production of protease inhibitors by postsurgical macrophages. J Surg Res. 16: 256–261.CrossRefGoogle Scholar
  40. Gay S, Viljanto J, Raekallio J, Penttinen R. (1978). Collagen types in early phases of wound healing in children. Acta Chir Scand. 144: 205–211.PubMedGoogle Scholar
  41. Gresser J, Brouty-Boye K, Thomas MG, Macierira-Cuelho A. (1970). Interferon and cell division I. Inhibition of the multiplication of mouse leukemia C12 106/B in vitro by interferon preparations. Proc Natl Acad Sci USA. 66: 1052–1058.PubMedCrossRefGoogle Scholar
  42. Grinnell F. (1984). Fibronectin and wound healing. J Cell Biochem. 26: 107–116.PubMedCrossRefGoogle Scholar
  43. Halme J, White C, Kauma S, Estes J, Haskell S. (1988). Peritoneal macrophages from patients with endomtriosis release growth factor activity in vitro. J Clin Endocrinol Metab. 66: 1044–1048.PubMedCrossRefGoogle Scholar
  44. Hibbs JB, Lambert LH, Remington JS. (1972). In vitro nonimmunologic destruction of cells with abnormal characteristics by adjuvant activated macrophages. Proc Soc Exp Biol Med. 139: 1049–1055.PubMedGoogle Scholar
  45. Hibbs JB, Taintor RR, Varrin Z, Rachlin EM. (1988). Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 157: 87–94.PubMedCrossRefGoogle Scholar
  46. Hormann H, Richter H, Jelinic V. (1987). The role of fibronectin fragments and cell-attached transamidase on the binding of soluble fibrin to macrophages. Thrombosis Res. 46: 39–50.CrossRefGoogle Scholar
  47. Johnson WJ, Steplewski Z, Matthews TJ, Koprowski H, Adams DO. (1986). Characterization of lytic conditions and requirements for effector activation. J Immunol 136: 4704–4713.PubMedGoogle Scholar
  48. Jones PA, Werb Z. (1980). Degradation of connective tissue matrices by macrophages. III. Influence of matrix composition on proteolysis of glycoprotein, elastin and collagen by macrophages in culture. J Exp Med. 152: 1527–1536.PubMedCrossRefGoogle Scholar
  49. Kauma S, Clark MR, White C, Halme J. (1988). Production of fibronectin by peritoneal macrophages and concentration of fibronectin in peritoneal fluid from patients with or without endometriosis. Obstet Gynecol. 72: 13–18.PubMedGoogle Scholar
  50. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ. (1988). Regulation of mRNAs for type I plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. J Biol Chem. 263: 3111–3115.PubMedGoogle Scholar
  51. Klebanoff SJ. (1975). Antimicrobial mechanisms of neutrophilic polymorpho-nuclear leukocytes. Semin Hematol. 12: 117–124.PubMedGoogle Scholar
  52. Kleinman HK, Klebe RJ, Martin GR. (1981). Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol. 88: 473–485.PubMedCrossRefGoogle Scholar
  53. Ko SD, Page RC, Narayanan AS. (1977). Fibroblast heterogenesity and prostaglandin regulation of subpopulation. Proc Natl Acad Sci USA. 74: 3429–3440.PubMedCrossRefGoogle Scholar
  54. Korn JH, Halushka PV, LeRoy EC. (1980). Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest. 65: 543–554.PubMedCrossRefGoogle Scholar
  55. Kung JT, Brooks SB, Jakway JB, Leonard LL, Talmadge DW. (1977). Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J Exp Med. 146: 665–680.PubMedCrossRefGoogle Scholar
  56. Kuraoka S, Campeau JD, Rodgers KE, Nakamura RM, diZerega GS. (1992). Effects of interleukin-1 (IL-1) on postsurgical macrophage secretion of protease and protease inhibitor activities. J Surg Res. 52: 71–78.PubMedCrossRefGoogle Scholar
  57. Kuraoka S, Campeau JD, Nakamura RM, diZerega GS. (in press.) Modulation of postsurgical macrophage function by early postsurgical polymorphonuclear leukocytes. J Surg Res.Google Scholar
  58. Kuraoka S, Campeau JD, Rodgers KE, Nakamura RM, diZerega GS. (in review). Modulation of cytotoxic activity of resident macrophages by postsurgical macrophages.Google Scholar
  59. Kurkinen M, Vaheri A, Roberts PJ, Stenman S. (1980). Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest. 43: 47–51.PubMedGoogle Scholar
  60. Laub R, Huybrechts-Godin G, Peeters-Joris C, Vaes G. (1982). Degradation of collagen and proteoglycan by macrophages and fibroblasts. Biochim Biophys Acta. 721: 425–433.PubMedCrossRefGoogle Scholar
  61. Leibovich SJ, Ross R. (1976). A macrophage-dependent factor that stimulates the proliferation of fibroblast in vitro. Am J Pathol. 84: 501–508.PubMedGoogle Scholar
  62. Matsushima K, Bano M, Kidwell WR, Oppenheim JJ. (1985). Interleukin-1 increases collagen type IV production by murine mammary epithelial cells. J Immunol. 134: 904–909.PubMedGoogle Scholar
  63. Meitzer MS, Ruco LP, Boraschi D, Nacy CA. (1979). Macrophage activation for tumor cytotoxicity: analysis of intermediary reaction. J Reticuloendothel Soc. 26: 403–416.Google Scholar
  64. Meuret G, Hoffmann G. (1973). Monocyte kinetic studies in normal and disease states. Br J Haematol 24: 275–285.PubMedCrossRefGoogle Scholar
  65. Meuret G, Bammert J, Hoffman G. (1974). Kinetics of human monocytopoiesis. Blood. 44: 801–806.PubMedGoogle Scholar
  66. Meuret G, Detel U, Kilz HP, Senn HJ, Van Lessen H. (1975). Human monocytopoiesis in acute and chronic inflammation. Expt Hematol. 54: 328–334.Google Scholar
  67. Nathan CF, Root KA. (1977). Hydrogen peroxide release from mouse peritoneal macrophages dependence on sequential activation and triggering. J Exp Med. 146: 1648–1662.PubMedCrossRefGoogle Scholar
  68. Nathan CF, Cohn ZA. (1980). Cellular components of inflammation: monocytes and macrophages. In: Kelley W, Harris E, Ruddey S, Hedge R, eds. Textbook of Rheumatology. Philadelphia: WB Saunders; 144–169.Google Scholar
  69. Nathan CF. (1986). Mechanisms of macrophage antimicrobial activity. Trans R Soc Trop Med Hyg. 77: 620–630.CrossRefGoogle Scholar
  70. Nelson DS. (1982). Macrophages as effector of cell-mediated immunity. In: Laskin AI, LeChevalier H, eds. Macrophages and Cellular Immunity. Cleveland: CRC Press; 45–76.Google Scholar
  71. Orita H, Campeau JD, Gale JA, Nakamura RM, diZerega GS. (1986). Differential secretion of plasminogen activator activity by postsurgical activated macrophages. J Surg Res. 41: 569–573.PubMedCrossRefGoogle Scholar
  72. Phan SH, McGarry BM, Loeffler KM, Kunkel SL. (1987). Regulation of macrophage derived fibroblast growth factor release by arachidonate metabolites. J Leukoc Biol. 42: 106–113.PubMedGoogle Scholar
  73. Postlethwaite AE, Lachman LB, Mainadri CL, Kang AH. (1983). Interleukin-1 stimulation of collagenase production by cultured fibroblasts. J Exp Med. 157: 801–806.PubMedCrossRefGoogle Scholar
  74. Raftery AT. (1973). Regeneration of parietal and visceral peritoneum: An electron microscopical study. J Anat. 115: 375–392.PubMedGoogle Scholar
  75. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. (1985). Type B transforming growth factor: a bifunctional regulatory of cellular growth. Proc Natl Acad Sci USA. 82: 119–123.PubMedCrossRefGoogle Scholar
  76. Roberts CJ, Birkenmeier TM, McQuillan JJ, Sporn MB. (1988). Transforming growth factor B stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem. 263: 4586–4592.PubMedGoogle Scholar
  77. Rodgers KE, Ellefson D, Girgis W, Scott L, diZerega GS. (1988). Effects of tolmetin sodium dihydrate on hormal and postsurgical cell function. Int J Immunopharmacol. 10: 111–120.PubMedCrossRefGoogle Scholar
  78. Samuelsson B, Branstrom E, Greer K, Hamberg M, Hammerstrom S. (1971). Prostaglandins. Anu Rev Biochem. 44: 669–694.CrossRefGoogle Scholar
  79. Schmidt JA, Mizel SB, Cohen D, Green I. (1982). Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol. 128: 2177–2192.PubMedGoogle Scholar
  80. Schnyder J, Dewald B, Baggiolini M. (1981). Effects of cyclooxygenase inhibitors and prostaglandin E2 on macrophage activation in vitro. Prostaglandins. 22: 411–419.PubMedCrossRefGoogle Scholar
  81. Schreiber R. (1984). Identification of 7-interferon as murine macrophage activating factor for tumor cytotoxicity. Comtemp Top Immunobiol. 13: 174–199.Google Scholar
  82. Shimanuki T, Nakamura RM, diZerega GS. (1986). A kinetic analysis of peritoneal fluid cytology and arachidonic acid metabolism after abrasion and reabrasion of rabbit peritoneum. J Surg Res. 41: 245–251.PubMedCrossRefGoogle Scholar
  83. Somers SD, Johnson WJ, Adams DO. (1986). Destruction of tumor cells by macrophages: mechanisms of recognition and lysis and their regulation. In: Herberman R, ed. Basic and Clinical Tumor Immunology. New York: Marcel-Dekker; 68–130.Google Scholar
  84. Spector WG. (1982). Experimental granulomas. Pathol Res Pract. 175: 110–117.PubMedGoogle Scholar
  85. Steeg PS, Johnson HM, Oppenheim JJ. (1982). Regulation of murine macrophage I-A antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxins. J Immunol. 129: 2402–2408.PubMedGoogle Scholar
  86. Steinman RM, Brodie SE, Cohn ZA. (1976). Membrane flow during pinocytosis: a stereologic analysis. J Cell Biol. 68: 665–671.PubMedCrossRefGoogle Scholar
  87. Steinman RM, Mellman IS, Muller WA, Cohn ZA. (1983). Endocytosis and the recycling of plasma membrane. J Cell Biol. 96: 1–27.PubMedCrossRefGoogle Scholar
  88. Stuehr DJ, Marletta MA. (1985). Mammalian nitrite biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA. 82: 7738–7742.PubMedCrossRefGoogle Scholar
  89. Stuehr DJ, Marletta MA. (1987). Induction of nitrite/nitrate synthesis in murine macrophages by, BCG infection, lymphokines or interfereγ. J Immunol. 139: 518–523.PubMedGoogle Scholar
  90. Unanue ER. (1986). Secretory function of mononuclear phagocytes. Am J Pathol. 83: 396–417.Google Scholar
  91. van Furth R, Cohn ZA. (1968). The origin and kinetics of mononuclear phagocytes. J Exp Med. 128: 415–435.PubMedCrossRefGoogle Scholar
  92. van Furth R, Diesselhoff-den MC. (1970). The kinetics of promonocytes and monocytes in the bone morrow. J Exp Med. 132: 813–828.PubMedCrossRefGoogle Scholar
  93. van Furth R. (1976). Origin and kinetics of mononuclear phagocytes. Ann NY Acad Sci. 278: 161–188.PubMedCrossRefGoogle Scholar
  94. van Furth R. (1988). Phagocytic cells: development and distribution of mono-nuclear phagocytes in normal steady-state and inflammation. In: Gallin JI, Goldstein IM, Synderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press; 281–295.Google Scholar
  95. Volkman A, Gowans JL. (1965). The origin of macrophages from bone marrow in the rat. Br J Exp Pathol. 46: 62–70.PubMedGoogle Scholar
  96. Volkman A. (1976). Disparity in origin of mononuclear phagocyte populations. J Reticuloendothel Soc. 19: 249–253.PubMedGoogle Scholar
  97. Werb Z, Banda MJ, Jones PA. (1980a). Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med. 152: 1340–1357.PubMedCrossRefGoogle Scholar
  98. Werb Z, Bainton DF, Jones PA. (1980b). Degradation of connective tissue matrices by macrophages. II. Morphological and biochemical studies on extracellular, pericellular and intracellular events in matrix proteolysis by macrophages in culture. J Exp Med. 152: 1537–1553.PubMedCrossRefGoogle Scholar
  99. Whitelaw DM. (1972). Observations on human monocyte kinetics after pulse labelling. Cell Tissue Kinet. 5: 311–317.PubMedGoogle Scholar
  100. Zucali JR, Dinarello CA, Obion DJ, Gross MA, Anderson L, Weiner RS. (1986). Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 77: 1857–1863.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin New York, Inc. 1992

Authors and Affiliations

  • Gere S. diZerega
    • 1
  • Kathleen E. Rodgers
    • 1
  1. 1.School of Medicine Livingston Research CenterUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations